The prevalence of tem and shv genes among extended-spectrum beta-lactamases producing escherichia coli and klebsiella pneumoniae

Iranian Journal of Basic Medical Sciences

Volumn 15, Issue 1, 2012, Pages 654-660

  Zaniani, Fatemeh Riyahi ^a   Meshkat, Zahra ^a   Nasab, Mahboubeh Naderi ^a   Khaje Karamadini, Mehrangiz ^a   Ghazvini, Kiarash ^a   Rezaee, Abdolrahim ^a   Esmaily, Habibollah ^a   Nabavinia, Maryam Sadat ^a   Hoseini, Mahboubeh Darban ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Escherichia coli; Extended spectrum beta lactamase (ESBL); Klebsiella pneumonia; PCR; Prevalence; SHV gene; TEM gene

Indexed keywords

BETA LACTAMASE SHV;

ARTICLE; BACTERIUM ISOLATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL PATIENT; HUMAN; IRAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTPATIENT; POLYMERASE CHAIN REACTION; PREVALENCE;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 84855586274     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kotra L, Samama J, Mobashery S. Beta-lactamases and resistance to beta-lactam antibiotics. Bacterial resistance to antimicrobials. NewYork: Marcel Decker; 2002. p.123-160.
2. Bradford PA. Extended spectrum beta-lactamases in the 21st century:characterization, epidemiology and the detection of this important resistance threat. Clin Microbiol Rev 2001; 14:933-951.
3. Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46:1481-1491.
4. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8:557-584.
5. Behrooozi A, Rahbar M, Vand Yousefi J. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebseilla pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res 2010; 4:881-884.
6. Ramazanzadeh R, Farhadifar F, Mansouri M. Etiology and antibiotic resistance pattern of community-acquired extended-spectrum beta-lactamas-producing gram negative isolates in Sanandaj. Res J Med Sci 2010; 4:243-247.
7. Kalematizadeh E. Determination of extended-spectrum beta-lactamases bacteria in Escherichia coli and Klebsiella pneumoniae. Mashhad: Mashhad University of Medical Sciences; 2008.
8. Hernández JR, Martínez-Martínez L, Cantón R, Coque TM, Pascual A. Nationwide study of escherichia coli and Klebsiella pneumoniae producing extended-spectrum -lactamases in Spain. Antimicrob Agents Chemother 2005;49:2122-2125.
9. Mansouri M, Ramazanzadeh R. Spread of extended-spectrum beta-lactamase producing Esherichia coli clinical isolates in Sanandaj hospitals. J Biol Sci 2009; 9:362-366.
10. Gniadkowski M. Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 2001; 7:597-608.
11. Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174:529-536.
12. Alcantar-Curiel D, Tinoco JC, Gayosso C, Carlos A, Daza C, Perez-Prado MC, et al. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 2004; 38:1067-1074.
13. Sambrook J, Russell DW. Molecular cloning. 3rd ed.New York (NY):Cold Spring Harbor; 2001.
14. M'Zali FH, Gascoyne-Binzi DM, Heritage J, Hawkey PM. Detection of mutations conferring extended-spectrum activity on SHV beta-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP). J Antimicrob Chemother 1996; 37:797-802.
15. Shahcheraghi F, Nasiri S, Noveiri H.The Survey of Genes Encoding Beta-Lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. Iran J Basic Med Sci 2010; 13:230-237.
16. Goossens H. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre types. J Antimicrob Chemother 2000; 46:39-52.
17. Varaiya A, Dogra J, Kulkarni M, Bhalekar P. Extended spectrum beta lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae n diabetic foot infection. Indian J Med Microbiol 2008; 26:281-282.
18. Yu WL, Chuang YC, Walther-Rasmussen J. Extendedspectrum β-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006; 39:264-277.
19. Chaikittisuk N, Munsrichoom A. Extended-spectrum β-Lactamase-producing escherichia coli and Klebsiella pneumoniae in children at Queen Sirikit National Institute of Child Health. J Infect Dis Antimicrob Agents 2007; 24:107-115.
20. Pai H. The characteristics of extended-spectrum β- lactamases in Korean isolates of Enterobactericeae. Yonsei Med J 1998; 39:514-519.
21. Jabeen K, Zafar A, Hasan R. Frequency and sensitivity pattern of extended-spectrum β-lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc 2005; 55:436-439.
22. Ullah F, Malik SA, Ahmed J. Antibiotic susceptibility pattern and ESBLS prevallence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol 2009; 8:3921-3926.
23. Fazly Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran. Acta Microbiol Immunol Hung 2009; 56:89-99.
24. Aminzadeh Z, Sadat KM, Sha'bani M. Bacteriuria by extendedspectrum Beta-lactamase-producing E. coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis 2008; 2:197-200.
25. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit 2006; 12: 362-365.
26. Mehrgan H, Rahbar M. Prevalence of extended-spectrum betalactamase- producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents 2008; 31:1471-1451.
27. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN. Prevalence and significance of a negative extended-spectrum-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific surveillance program. J Clin Microbiol 2007; 45:1478-1482.
28. Masjedian Jazi F, Valehi F, Talebi A, Rastegar Lari A. Molecular characterization of resistance to Extended -Spectrum antibiotics in Escherichia coli and Klebsiella pneumoniae. Iran J Med Microbiol 2007; 2:27-34 (In Persian).
29. Shahcheragh F, Nasiri S, Noveiri H. Detection of extended-spectrum β-lactamases (ESBLs) in Escherichia coli. Iran J Clin Infect Dis 2009; 4:63-70.
30. Taşli H, Bahar IH. Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis 2005; 58:162-167.
31. Ramazanzadeh R. Prevalence and characterization of extended-spectrum beta-lactamase production in clinical isolates of Klebsiella spp. Afr J Microbiol Res 2010; 4:1359-1362.